US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Healthcare 2x Daily ETF

31.15

-0.1214-0.39%

Post-market: 31.460.3056+0.98%16:10 EDT

Volume:4K

Turnover:112.74K

Market Cap:623.07K

PE:- -

High:31.86

Open:31.85

Low:31.15

Close:31.27

52wk High:35.56

52wk Low:25.40

Shares:20.00K

Float Shares:20.00K

Volume Ratio:3.32

T/O Rate:17.82%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Roche receives FDA approval for companion diagnostic tests for Ziihera

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Humana (HUM) Targets 10,000 Medicare Advantage Members In Kidney Care Partnership

Simply Wall St.

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

Think Medicare Advantage Provides Better Care for Chronic Conditions? a New Study Suggests Otherwise.

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

Regeneron’s Pasatru granted FDA approval for FOP

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/XLVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XLVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVX\",,,,,undefined,":{"symbol":"XLVX","market":"US","secType":"STK","nameCN":"Corgi U.S. Healthcare 2x Daily ETF","latestPrice":31.1534,"timestamp":1789156800000,"preClose":31.2748,"halted":0,"volume":3564,"hourTrading":{"tag":"盘后","latestPrice":31.459,"preClose":31.1534,"latestTime":"16:10 EDT","volume":4,"amount":124.6136,"timestamp":1789157404981,"change":0.3056,"changeRate":0.00981,"amplitude":0},"delay":0,"changeRate":-0.0038817194674305748,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"Market Closed","change":-0.1214,"latestTime":"09-11 16:00:00 EDT","open":31.85,"high":31.86,"low":31.1534,"amount":112737,"amplitude":0.022593,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":31.2748,"nav":31.24,"aum":624800,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.459,"preClose":31.1534,"latestTime":"16:10 EDT","volume":4,"amount":124.6136,"timestamp":1789157404981,"change":0.3056,"changeRate":0.00981,"amplitude":0},"volumeRatio":3.3240064361494315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVX\",,,,,undefined,":{"symbol":"XLVX","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.3240064361494315,"shares":20000,"dividePrice":0,"high":31.86,"amplitude":0.022593,"preClose":31.2748,"low":31.1534,"week52Low":25.3968,"pbRate":"--","week52High":35.56,"institutionHeld":0,"latestPrice":31.1534,"eps":0,"divideRate":0,"volume":3564,"delay":0,"ttmEps":0,"open":31.85,"prevYearClose":25.46,"prevWeekClose":33.4987,"prevMonthClose":33.2893,"prevQuarterClose":29.402,"fiveDayClose":34.2893,"twentyDayClose":32.6044,"sixtyDayClose":27.1193},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLVX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLVX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","PSCH","IYH","LABU","TECB","MRNX","IEIH","LFSC","GNMX","BMED","SRRK","NVIB","RSPH","IBRN","BK4588","PINK","XLVX","SYNB","IBB","BK4139","THNR","MEDI","BK4585","TBXU","BBP","FRTY","MRNY","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","MEDI","RSPH","IEIH","LFSC","IDNA","SYNB","MRNX","GDOC","NVIB","TECB","IBB","FRTY","LABU","BMED","BK4588","XLVX","IYH","PSCH","BBP","BK4585","MRNY","TBXU","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665458363","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2665458363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665458363?lang=en_us&edition=fundamental","pubTime":"2026-09-05 22:15","pubTimestamp":1788617700,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","XHS","LU0320765489.SGD","LU0417517546.SGD","IYH","FXH","BK4533","UNHW","LU1093756168.USD","LU0170899867.USD","BK4154","SG9999014013.SGD","HUM","LU0238689110.USD","LNGR","LU0208291251.USD","LU0266013472.USD","LU0390134368.USD","LU1093756325.SGD","BK4566","UN","LU1983260115.SGD","LU0070302665.USD","SG9999014005.SGD","SG9999014021.USD","UNHU","BK4585","UNHG","IHF","LU0256863811.USD","XLVX","BK4588","LU0348723411.USD","IEHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","HELX","BBP","EKG","GNOM","IYH","LU0889565916.HKD","NVIB","IDNA","PTH","IEIH","GNMX","TECB","FFOX","BK4196","BK4588","MRNY","GH","PSCH","SYNB","LU0320765992.SGD","PINK","IBB","LFSC","MRNX","TBXU","BK4551","GDOC","BMED","XLVX","LU0109394709.USD","BK4535","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805403","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805403","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805403?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:23","pubTimestamp":1788456180,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","SG9999014013.SGD","LNGR","LU0266013472.USD","LU0256863811.USD","LU0170899867.USD","LU0417517546.SGD","LU0211331839.USD","LU0390134368.USD","SG9999014005.SGD","BK4585","LU0070302665.USD","SG9999014021.USD","LU0348723411.USD","LU1093756325.SGD","BK4154","IYH","HUM","UNHG","IEHS","BK4588","IHF","UNHW","LU0238689110.USD","LU0320765489.SGD","UN","FXH","LU1093756168.USD","BK4566","XHS","XLVX","LU1983260115.SGD","BK4533","UNHU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664443848","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2664443848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664443848?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:04","pubTimestamp":1788365040,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","LU0320765489.SGD","LNGR","LU0170899867.USD","LU0070302665.USD","IHF","UNHU","BK4566","FXH","BK4154","HUM","LU0238689110.USD","IEHS","SG9999014005.SGD","LU0211331839.USD","IYH","SG9999014021.USD","UNHG","LU0266013472.USD","LU0208291251.USD","XHS","LU0348723411.USD","BK4585","LU1093756168.USD","LU0256863811.USD","LU1093756325.SGD","LU0390134368.USD","SG9999014013.SGD","UN","LU0417517546.SGD","BK4588","XLVX","BK4533","UNHW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","PSCH","TECB","IYH","RSPH","BMED","LABU","NVIB","SYNB","XLVX","GDOC","MRNX","TBXU","PINK","GNMX","LFSC","IEIH","MEDI","TAK","BBP","BK4585","FRTY","IBB","BK4139","IDNA","BK4007","MRNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","MRNY","IEIH","RSPH","MRNX","BMED","LFSC","SYNB","TBXU","NVIB","FRTY","TECB","BK4588","PSCH","IBB","MEDI","BBP","PINK","BK4585","GNMX","LABU","GDOC","IYH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BBP","BK4007","IYH","NVIB","IDNA","IEIH","GNMX","TECB","MRNY","BK4588","PSCH","SYNB","PINK","IBB","LFSC","MRNX","TAK","TBXU","GDOC","BMED","XLVX","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GNMX","IBB","BK4007","FRTY","SYNB","MRNX","IEIH","BBP","TECB","GDOC","IDNA","IYH","BK4585","TBXU","HRTS","RSPH","LFSC","RHHBY","BK4588","BMED","XLVX","PINK","CANC","MRNY","PSCH","03165","LABU","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE0009354923.USD","IE00BJJMRZ35.SGD","TBXU","BBH","NVIB","PSCH","MRNX","BBP","TECB","BMED","BK4588","CANC","GNMX","RVMD","LABU","IBB","SYNB","LU0320765992.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE0002141913.USD","MRNY","RSPH","XLVX","IDNA","LU0889565916.HKD","BK4585","FRTY","PINK","GDOC","MEDI","IE00B4R5TH58.HKD","IE0009355771.USD","IYH","PTH","IE00BJT1NW94.SGD","IEIH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","IYH","GDOC","RVMD","MRNY","BBH","IE00BFTCPJ56.SGD","LFSC","BMED","IE00BJJMRZ35.SGD","MRNX","IE0002141913.USD","IE00B2B36J28.USD","BK4139","CANC","SYNB","RSPH","BBP","TBXU","IE00BJT1NW94.SGD","IDNA","BK4585","NVIB","BK4588","FRTY","XLVX","LABU","PSCH","TECB","LU0320765992.SGD","PINK","IE0009355771.USD","PTH","IBB","IEIH","MEDI","IE0009354923.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662915759","title":"Humana (HUM) Targets 10,000 Medicare Advantage Members In Kidney Care Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2662915759","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662915759?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:18","pubTimestamp":1787678306,"startTime":"0","endTime":"0","summary":"Humana (NYSE:HUM) and DaVita have launched a new coordinated value-based care partnership for Medicare Advantage members with chronic kidney disease.\nThe program targets over 10,000 Medicare Advantage members and focuses on earlier intervention to slow disease progression and reduce hospitalizations.\nThe collaboration expands Humana's value-based care model by integrating DaVita's kidney care expertise into Humana's existing Medicare Advantage footprint.\n\nFor investors tracking how health...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-targets-10000-medicare-advantage-members-in-kidne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-targets-10000-medicare-advantage-members-in-kidne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7093","LU0211331839.USD","SG9999014021.USD","LU0266013472.USD","LU0170899867.USD","LU0348723411.USD","UNHG","HUM","SG9999014013.SGD","LU1983260115.SGD","LU0256863811.USD","UNHU","BK4154","SG9999014005.SGD","BK4533","UN","LU0208291251.USD","BK4566","UNHW","LU0417517546.SGD","FXH","IEHS","IYH","LNGR","LU1093756168.USD","LU0390134368.USD","LU0238689110.USD","XLVX","BK7500","BK4585","XHS","IHF","BK4588","LU1093756325.SGD","HUM.AU","LU0070302665.USD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","LABU","GNMX","IYH","IEIH","ONC","BMED","TBXU","IDNA","PINK","NVIB","BK4585","BBP","RSPH","BK4588","LFSC","MRNX","GDOC","XLVX","BK4139","TECB","MEDI","SYNB","FRTY","MRNY","PSCH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274273","title":"Think Medicare Advantage Provides Better Care for Chronic Conditions? a New Study Suggests Otherwise.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661274273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:19","pubTimestamp":1787570340,"startTime":"0","endTime":"0","summary":"Medicare Advantage enrollees with diabetes aren't healthier than Americans on traditional Medicare - despite the grocery and gym perksA new study examined whether people who enroll in Medicare Advanta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNHU","SG9999014013.SGD","XLVX","LU0211331839.USD","LU0256863811.USD","LU0266013472.USD","LU0348723411.USD","UN","HUM","BK4533","BK4154","IYH","LU0070302665.USD","IHF","LU0170899867.USD","UNHW","LU0417517546.SGD","LU0320765489.SGD","FXH","LU1093756168.USD","LU0238689110.USD","LU1093756325.SGD","SG9999014005.SGD","LU1983260115.SGD","IEHS","BK4566","LU0390134368.USD","LNGR","BK4585","SG9999014021.USD","XHS","LU0208291251.USD","UNHG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245464","title":"My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661245464?lang=en_us&edition=fundamental","pubTime":"2026-08-24 03:30","pubTimestamp":1787513400,"startTime":"0","endTime":"0","summary":"You can email The Moneyist with any financial and ethical questions at qfottrell@marketwatch.com. The Moneyist regrets he cannot reply to questions individually.Some people will get paid under the table. Others will see every last dime go through Uncle Sam.Dear Mother,Don't worry about other people who may or may not game the system.Compare and despair. That is a thankless task. Some people will get paid under the table. Others will see every last dime go through Uncle Sam. There's no accounting for others. Let them do their thing. Your son has, perhaps, been given a rougher deal: Even though he is a full-time student with little or no income, he still pays about $500 for health insurance. However, the settlement itself is probably not the real reason for his high premium. Is it fair?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","LU2355687059.USD","LU0417517546.SGD","LU0433182093.SGD","LU1983260115.SGD","FHLC","SG9999014021.USD","XHS","LU1093756325.SGD","SG9999014039.USD","LU1119994496.HKD","LU0320765489.SGD","LU0029864427.USD","LU0128525929.USD","BK4533","SG9999014013.SGD","FXH","LU0882574055.USD","XLVX","LU0868494617.USD","CURE","LU0310800379.SGD","LU0985489474.SGD","BK4504","LU0708994859.HKD","LU0648001328.SGD","HCA","LU1084165304.USD","IYH","LU0211331839.USD","JHMH","BK4588","LU1150488218.USD","IE00B3S45H60.SGD","LU0390134368.USD","LU0238689110.USD","LU1261432733.SGD","BK4566","IHF","LU0114720955.EUR","LU0256863811.USD","LU0266013472.USD","LU0203345920.USD","LU1489326972.SGD","HUM","LU0170899867.USD","LU1201861249.SGD","LU0070302665.USD","BK4185","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661583712","title":"My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661583712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661583712?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:00","pubTimestamp":1787266800,"startTime":"0","endTime":"0","summary":"You can email The Moneyist with any financial and ethical questions at qfottrell@marketwatch.com. The Moneyist regrets he cannot reply to questions individually.Some people will get paid under the table. Others will see every last dime go through Uncle Sam.Dear Mother,Don't worry about other people who may or may not game the system.Compare and despair. That is a thankless task. Some people will get paid under the table. Others will see every last dime go through Uncle Sam. There's no accounting for others. Let them do their thing. Your son has, perhaps, been given a rougher deal: Even though he is a full-time student with little or no income, he still pays about $500 for health insurance. However, the settlement itself is probably not the real reason for his high premium. Is it fair?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1150488135.SGD","JHMH","LU1267930490.SGD","HCA","LU0868494617.USD","LU0985489474.SGD","LU0417517546.SGD","LU0128525929.USD","LU0203347892.USD","LU1150488218.USD","LU0708994859.HKD","LU1983260115.SGD","LU0170899867.USD","LU1201861249.SGD","LU1093756168.USD","LU1267930573.SGD","LU0878866978.SGD","LU0320765489.SGD","XHS","FXH","LU0211328371.USD","LU1261432733.SGD","BK4185","LU0208291251.USD","LU1489326972.SGD","HUM","IYH","BK4566","LU0348723411.USD","LU0648001328.SGD","RSPH","IE00B775SV38.USD","LU0070302665.USD","LU2355687059.USD","BK4504","LU0266013472.USD","IHF","LU1119994496.HKD","CURE","LU0029864427.USD","FHLC","LU0068578508.USD","SG9999014005.SGD","SG9999014013.SGD","LU0203345920.USD","XLVX","LU0310800379.SGD","LU0114720955.EUR","LU0211327993.USD","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","FRTY","MRNX","TECB","BK4585","IDNA","IEIH","GDOC","IYH","BMED","LFSC","PSCH","RSPH","NVIB","IBB","BK4588","PINK","MEDI","TBXU","BBP","SYNB","LABU","XLVX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","PINK","XLVX","PSCH","FRTY","BBP","LFSC","BMED","MEDI","BK4585","TBXU","MRNY","SYNB","IYH","GDOC","IDNA","NVIB","BK4588","IEIH","GNMX","TECB","MRNX","LABU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424363","title":"My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424363?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:30","pubTimestamp":1787153400,"startTime":"0","endTime":"0","summary":"You can email The Moneyist with any financial and ethical questions at qfottrell@marketwatch.com. The Moneyist regrets he cannot reply to questions individually.Some people will get paid under the table. Others will see every last dime go through Uncle Sam.Dear Mother,Don't worry about other people who may or may not game the system.Compare and despair. That is a thankless task. Some people will get paid under the table. Others will see every last dime go through Uncle Sam. There's no accounting for others. Let them do their thing. Your son has, perhaps, been given a rougher deal: Even though he is a full-time student with little or no income, he still pays about $500 for health insurance. However, the settlement itself is probably not the real reason for his high premium. Is it fair?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","LU0187121727.USD","IYH","LU0238689110.USD","LU1084165304.USD","LU0433182093.SGD","LU0320765489.SGD","BK4566","LU0390134368.USD","LU1201861249.SGD","BK4533","LU0170899867.USD","LU1261432733.SGD","BK4504","LU1267930490.SGD","LU1267930573.SGD","LU0208291251.USD","RSPH","LU0648001328.SGD","CURE","SG9999014021.USD","SG9999014005.SGD","LU0985489474.SGD","LU0980610538.SGD","LU0130102774.USD","FHLC","LU1150488218.USD","LU1119994496.HKD","JHMH","SG9999014013.SGD","IHF","XLVX","LU0203347892.USD","HUM","LU0211331839.USD","LU1489326972.SGD","XHS","LU0868494617.USD","BK4185","LU1150488135.SGD","LU0266013472.USD","IE00B3S45H60.SGD","LU0203345920.USD","BK4585","IE00B775SV38.USD","FXH","HCA","LU1093756168.USD","LU0878866978.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}